Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review
Melatonin (<i>N</i>-acetyl-5-methoxytryptamine) is an indoleamine with antioxidant, chronobiotic and anti-inflammatory properties; reduced levels of this hormone are associated with higher risk of cancer. Several beneficial effects of melatonin have been described in a broad number of tu...
Saved in:
Main Authors: | Paula Fernández-Palanca (Author), Carolina Méndez-Blanco (Author), Flavia Fondevila (Author), María J. Tuñón (Author), Russel J. Reiter (Author), José L. Mauriz (Author), Javier González-Gallego (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
by: Javier Egea, et al.
Published: (2022) -
Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
by: Doris Loh, et al.
Published: (2021) -
Clinical Uses of Melatonin in Pediatrics
by: Emilio J. Sánchez-Barceló, et al.
Published: (2011) -
Editorial: Therapeutic Advances in Melatonin Research
by: Francisco López-Muñoz, et al.
Published: (2022) -
Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
by: Hadis Zare, et al.
Published: (2019)